Evidence map›Paper›PMID 24586882›Full record

ArticlePloS one2014

Impact of antiretroviral therapy on renal function among HIV-infected Tanzanian adults: a retrospective cohort study.

Bonaventura C T Mpondo, Samuel E Kalluvya, Robert N Peck, Rodrick Kabangila, Benson R Kidenya, Lucheri Ephraim, Daniel W Fitzgerald, Jennifer A Downs

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Factors Associated with Antiretroviral Therapy Toxicity Out-Comes in Patients with and without Hypertension.International journal of environmental research and public health · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bonaventura C T MpondoDepartment of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania ; Department of Medicine, Bugando Medical Centre, Mwanza, Tanzania.
Samuel E KalluvyaDepartment of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania ; Department of Medicine, Bugando Medical Centre, Mwanza, Tanzania.
Robert N PeckDepartment of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania ; Department of Medicine, Bugando Medical Centre, Mwanza, Tanzania ; Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America.
Rodrick KabangilaDepartment of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania ; Department of Medicine, Bugando Medical Centre, Mwanza, Tanzania.
Benson R KidenyaDepartment of Biochemistry and Molecular Biology, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Lucheri EphraimDepartment of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania ; Department of Medicine, Bugando Medical Centre, Mwanza, Tanzania.
Daniel W FitzgeraldDepartment of Medicine, Weill Cornell Medical College, New York, New York, United States of America.
Jennifer A DownsDepartment of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania ; Department of Medicine, Bugando Medical Centre, Mwanza, Tanzania ; Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America.

Funding

TUBERCULOSIS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW000018 · FIC · WEILL MEDICAL COLL OF CORNELL UNIV · PI JOHNSON, WARREN DOUGLAS · 1988 to 2012
$16.1M
Global Health Research Training in HIV and TuberculosisK24AI098627 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI FITZGERALD, DANIEL W · 2012 to 2022
$1.8M
FIC NIH HHS D43 TW000018FIC NIH HHS TW 00018NIAID NIH HHS K24 AI098627
6 · The paper itself

Abstract

backgroundData regarding the outcomes of HIV-infected adults with baseline renal dysfunction who start antiretroviral therapy are conflicting.

methodsWe followed up a previously-published cohort of HIV-infected adult outpatients in northwest Tanzania who had high prevalence of renal dysfunction at the time of starting antiretroviral therapy (between November 2009 and February 2010). Patients had serum creatinine, proteinuria, microalbuminuria, and CD4(+) T-cell count measured at the time of antiretroviral therapy initiation and at follow-up. We used the adjusted Cockroft-Gault equation to calculate estimated glomerular filtration rates (eGFRs).

resultsIn this cohort of 171 adults who had taken antiretroviral therapy for a median of two years, the prevalence of renal dysfunction (eGFR <90 mL/min/1.73 m(2)) decreased from 131/171 (76.6%) at the time of ART initiation to 50/171 (29.2%) at the time of follow-up (p<0.001). Moderate dysfunction (eGFR<60 mL/min/1.73 m(2)) decreased from 21.1% at antiretroviral therapy initiation to 1.1% at follow-up (p<0.001), as did the prevalence of microalbuminuria (72% to 44%, p<0.001). Use of tenofovir was not associated with renal dysfunction at follow-up.

conclusionMild and moderate renal dysfunction were common in this cohort of HIV-infected adults initiating antiretroviral therapy, and both significantly improved after a median follow-up time of 2 years. Our work supports the renal safety of antiretroviral therapy in African adults with mild-moderate renal dysfunction, suggesting that these regimens do not lead to renal damage in the majority of patients and that they may even improve renal function in patients with mild to moderate renal dysfunction.

Indexed as

AdultAntiretroviral Therapy, Highly ActiveFemaleFollow-Up StudiesGlomerular Filtration RateHIVHIV InfectionsHumansKidney Function TestsMalePrevalencePrognosisRenal InsufficiencyRetrospective StudiesRisk FactorsSurvival Rate

Identifiers

PMID24586882
PMCPMC3935873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.